

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation by symbiont of host defense response (GO:0052509) | 6.20426066 |
| 2 | modulation by symbiont of host defense response (GO:0052031) | 6.20426066 |
| 3 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.20426066 |
| 4 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.20426066 |
| 5 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.20426066 |
| 6 | modulation by symbiont of host immune response (GO:0052553) | 6.20426066 |
| 7 | neutrophil mediated immunity (GO:0002446) | 5.28252384 |
| 8 | neutrophil activation involved in immune response (GO:0002283) | 5.28070061 |
| 9 | regulation of interferon-beta biosynthetic process (GO:0045357) | 5.08102192 |
| 10 | natural killer cell mediated immunity (GO:0002228) | 4.95961004 |
| 11 | natural killer cell mediated cytotoxicity (GO:0042267) | 4.95961004 |
| 12 | regulation of vitamin D biosynthetic process (GO:0060556) | 4.89236433 |
| 13 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.69465876 |
| 14 | macroautophagy (GO:0016236) | 4.59877643 |
| 15 | oligosaccharide catabolic process (GO:0009313) | 4.56654795 |
| 16 | phospholipid homeostasis (GO:0055091) | 4.50646002 |
| 17 | regulation of fever generation (GO:0031620) | 4.49457723 |
| 18 | glycosphingolipid catabolic process (GO:0046479) | 4.40125323 |
| 19 | macrophage activation involved in immune response (GO:0002281) | 4.34392600 |
| 20 | cellular response to thyroid hormone stimulus (GO:0097067) | 4.33905516 |
| 21 | regulation of mononuclear cell migration (GO:0071675) | 4.12670917 |
| 22 | positive regulation of p38MAPK cascade (GO:1900745) | 4.00844726 |
| 23 | glycolipid catabolic process (GO:0019377) | 4.00347495 |
| 24 | I-kappaB phosphorylation (GO:0007252) | 3.94307253 |
| 25 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.94206694 |
| 26 | negative regulation of interleukin-12 production (GO:0032695) | 3.91218292 |
| 27 | response to host immune response (GO:0052572) | 3.89795439 |
| 28 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.89795439 |
| 29 | regulation of vitamin metabolic process (GO:0030656) | 3.88616840 |
| 30 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.85694708 |
| 31 | L-alpha-amino acid transmembrane transport (GO:1902475) | 3.84979878 |
| 32 | pinocytosis (GO:0006907) | 3.83818645 |
| 33 | myeloid leukocyte mediated immunity (GO:0002444) | 3.81350875 |
| 34 | lipoprotein transport (GO:0042953) | 3.78737311 |
| 35 | negative regulation of lipid storage (GO:0010888) | 3.72062609 |
| 36 | regulation of integrin activation (GO:0033623) | 3.67979704 |
| 37 | negative regulation of cell killing (GO:0031342) | 3.67265591 |
| 38 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.67265591 |
| 39 | positive regulation of interferon-alpha production (GO:0032727) | 3.66864538 |
| 40 | regulation of chronic inflammatory response (GO:0002676) | 3.66371107 |
| 41 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.65452405 |
| 42 | ceramide catabolic process (GO:0046514) | 3.64673521 |
| 43 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.64352101 |
| 44 | regulation of heat generation (GO:0031650) | 3.59652324 |
| 45 | response to muramyl dipeptide (GO:0032495) | 3.59128901 |
| 46 | regulation of interferon-alpha production (GO:0032647) | 3.50241348 |
| 47 | regulation of podosome assembly (GO:0071801) | 3.49748414 |
| 48 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.45558359 |
| 49 | response to lipoprotein particle (GO:0055094) | 3.44590954 |
| 50 | neutrophil activation (GO:0042119) | 3.42593410 |
| 51 | modulation by symbiont of host cellular process (GO:0044068) | 3.40075740 |
| 52 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.40069092 |
| 53 | apoptotic cell clearance (GO:0043277) | 3.39857344 |
| 54 | basic amino acid transport (GO:0015802) | 3.37654710 |
| 55 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.37197686 |
| 56 | response to host (GO:0075136) | 3.37197686 |
| 57 | response to host defenses (GO:0052200) | 3.37197686 |
| 58 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.37013703 |
| 59 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.36810204 |
| 60 | myeloid cell activation involved in immune response (GO:0002275) | 3.36733893 |
| 61 | germinal center formation (GO:0002467) | 3.36729361 |
| 62 | granulocyte activation (GO:0036230) | 3.36140575 |
| 63 | response to peptidoglycan (GO:0032494) | 3.33485135 |
| 64 | microglial cell activation (GO:0001774) | 3.30608510 |
| 65 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.30174013 |
| 66 | response to thyroid hormone (GO:0097066) | 3.28214258 |
| 67 | regulation of chemokine biosynthetic process (GO:0045073) | 3.27968651 |
| 68 | negative regulation of interleukin-1 beta production (GO:0032691) | 3.27727363 |
| 69 | histone H3-K4 trimethylation (GO:0080182) | 3.26548963 |
| 70 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.26473145 |
| 71 | cell adhesion mediated by integrin (GO:0033627) | 3.23716149 |
| 72 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.22980904 |
| 73 | membrane lipid catabolic process (GO:0046466) | 3.18812343 |
| 74 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.18750052 |
| 75 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.18122503 |
| 76 | monocyte chemotaxis (GO:0002548) | 3.16774168 |
| 77 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 3.11489680 |
| 78 | early endosome to late endosome transport (GO:0045022) | 3.11221275 |
| 79 | regulation of nitric oxide biosynthetic process (GO:0045428) | 3.05607028 |
| 80 | macrophage activation (GO:0042116) | 3.02603545 |
| 81 | regulation of mast cell degranulation (GO:0043304) | 3.02196498 |
| 82 | B cell homeostasis (GO:0001782) | 3.01275952 |
| 83 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 3.00878397 |
| 84 | sphingolipid catabolic process (GO:0030149) | 3.00690682 |
| 85 | positive regulation of leukocyte apoptotic process (GO:2000108) | 2.99645188 |
| 86 | negative regulation of interleukin-1 production (GO:0032692) | 2.99514054 |
| 87 | T-helper 1 type immune response (GO:0042088) | 2.99444640 |
| 88 | positive regulation of antigen processing and presentation (GO:0002579) | 2.98530379 |
| 89 | leukocyte mediated cytotoxicity (GO:0001909) | 2.97123291 |
| 90 | adhesion of symbiont to host cell (GO:0044650) | 2.95967089 |
| 91 | virion attachment to host cell (GO:0019062) | 2.95967089 |
| 92 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.93437288 |
| 93 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.92011959 |
| 94 | modification by symbiont of host morphology or physiology (GO:0044003) | 2.90629023 |
| 95 | positive regulation of cholesterol efflux (GO:0010875) | 2.89699904 |
| 96 | negative regulation of mast cell activation (GO:0033004) | 2.88662088 |
| 97 | regulation of cholesterol storage (GO:0010885) | 2.84542313 |
| 98 | positive regulation of B cell differentiation (GO:0045579) | 2.84168320 |
| 99 | eosinophil chemotaxis (GO:0048245) | 2.83837968 |
| 100 | developmental pigmentation (GO:0048066) | 2.83789254 |
| 101 | positive regulation of heat generation (GO:0031652) | 2.83409414 |
| 102 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.82212535 |
| 103 | positive regulation of lipid storage (GO:0010884) | 2.81740831 |
| 104 | negative regulation of granulocyte differentiation (GO:0030853) | 2.81582902 |
| 105 | osteoclast differentiation (GO:0030316) | 2.80668506 |
| 106 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.79952647 |
| 107 | cytidine deamination (GO:0009972) | 2.79556900 |
| 108 | cytidine metabolic process (GO:0046087) | 2.79556900 |
| 109 | cytidine catabolic process (GO:0006216) | 2.79556900 |
| 110 | tryptophan catabolic process (GO:0006569) | 2.79073930 |
| 111 | indole-containing compound catabolic process (GO:0042436) | 2.79073930 |
| 112 | indolalkylamine catabolic process (GO:0046218) | 2.79073930 |
| 113 | cellular response to ethanol (GO:0071361) | 2.78948563 |
| 114 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.77651689 |
| 115 | ovulation from ovarian follicle (GO:0001542) | 2.77396210 |
| 116 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.77052894 |
| 117 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 2.75648197 |
| 118 | viral entry into host cell (GO:0046718) | 2.75273179 |
| 119 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 2.75257105 |
| 120 | G-protein coupled receptor internalization (GO:0002031) | 2.73602638 |
| 121 | wound healing, spreading of epidermal cells (GO:0035313) | 2.71980802 |
| 122 | regulation of leukocyte degranulation (GO:0043300) | 2.71065401 |
| 123 | respiratory burst (GO:0045730) | 2.70260595 |
| 124 | positive regulation of interferon-beta production (GO:0032728) | 2.68026429 |
| 125 | negative regulation of interleukin-6 production (GO:0032715) | 2.67981610 |
| 126 | myeloid dendritic cell differentiation (GO:0043011) | 2.67118939 |
| 127 | regulation of mast cell activation (GO:0033003) | 2.66905948 |
| 128 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.66835687 |
| 129 | positive regulation of insulin receptor signaling pathway (GO:0046628) | 2.66821849 |
| 130 | regulation of lipid storage (GO:0010883) | 2.65380664 |
| 131 | nerve growth factor signaling pathway (GO:0038180) | 2.64858184 |
| 132 | cellular response to lipopolysaccharide (GO:0071222) | 2.64829407 |
| 133 | autophagic vacuole fusion (GO:0000046) | 2.64808593 |
| 134 | immunoglobulin mediated immune response (GO:0016064) | 2.62805529 |
| 135 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.62604562 |
| 136 | regulation of sequestering of triglyceride (GO:0010889) | 2.62330161 |
| 137 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.61434881 |
| 138 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.61434881 |
| 139 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.61434881 |
| 140 | mannose metabolic process (GO:0006013) | 2.61285436 |
| 141 | regulation of alkaline phosphatase activity (GO:0010692) | 2.61009558 |
| 142 | adhesion of symbiont to host (GO:0044406) | 2.60309378 |
| 143 | low-density lipoprotein particle clearance (GO:0034383) | 2.58941172 |
| 144 | regulation of protein polyubiquitination (GO:1902914) | 2.58587919 |
| 145 | positive regulation of T cell apoptotic process (GO:0070234) | 2.58300227 |
| 146 | positive regulation of interleukin-6 production (GO:0032755) | 2.57599350 |
| 147 | positive regulation of cholesterol transport (GO:0032376) | 2.57199257 |
| 148 | positive regulation of sterol transport (GO:0032373) | 2.57199257 |
| 149 | positive regulation of acute inflammatory response (GO:0002675) | 2.57172351 |
| 150 | negative regulation of amino acid transport (GO:0051956) | 2.56385466 |
| 151 | positive regulation of phagocytosis (GO:0050766) | 2.56169760 |
| 152 | cellular response to molecule of bacterial origin (GO:0071219) | 2.54775310 |
| 153 | response to nerve growth factor (GO:1990089) | 2.54410726 |
| 154 | cellular response to nerve growth factor stimulus (GO:1990090) | 2.54410726 |
| 155 | lysosome organization (GO:0007040) | 2.54395937 |
| 156 | amino sugar catabolic process (GO:0046348) | 2.53999534 |
| 157 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.53919417 |
| 158 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.52139460 |
| 159 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.52066740 |
| 160 | detection of molecule of bacterial origin (GO:0032490) | 2.49529946 |
| 161 | regulation of immunoglobulin secretion (GO:0051023) | 2.48481584 |
| 162 | ovulation (GO:0030728) | 2.48039103 |
| 163 | eosinophil migration (GO:0072677) | 2.47854507 |
| 164 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.47300526 |
| 165 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.47286104 |
| 166 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.45139646 |
| 167 | kynurenine metabolic process (GO:0070189) | 2.45026246 |
| 168 | regulation of macrophage chemotaxis (GO:0010758) | 2.43957317 |
| 169 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.42534222 |
| 170 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.41914581 |
| 171 | positive regulation of type 2 immune response (GO:0002830) | 2.41338770 |
| 172 | lipid storage (GO:0019915) | 2.38309214 |
| 173 | regulation of NF-kappaB import into nucleus (GO:0042345) | 2.34859783 |
| 174 | cellular response to nicotine (GO:0071316) | 2.34678756 |
| 175 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 2.34380704 |
| 176 | vitamin D metabolic process (GO:0042359) | 2.34029459 |
| 177 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.32980957 |
| 178 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.32901631 |
| 179 | regulation of interleukin-12 production (GO:0032655) | 2.31817431 |
| 180 | keratan sulfate catabolic process (GO:0042340) | 2.31498491 |
| 181 | cellular response to arsenic-containing substance (GO:0071243) | 2.30340426 |
| 182 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.28884232 |
| 183 | plasma lipoprotein particle clearance (GO:0034381) | 2.28210410 |
| 184 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.28016565 |
| 185 | sphingosine metabolic process (GO:0006670) | 2.27295290 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 5.02695645 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.62329551 |
| 3 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.40712885 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.35404031 |
| 5 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.85340484 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.70539748 |
| 7 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.45112302 |
| 8 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.70032074 |
| 9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.63358274 |
| 10 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.50247147 |
| 11 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.44821673 |
| 12 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.39496987 |
| 13 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.32052830 |
| 14 | SPI1_23127762_ChIP-Seq_K562_Human | 2.27350311 |
| 15 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.12821437 |
| 16 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.12006108 |
| 17 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 2.04662811 |
| 18 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.97890498 |
| 19 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.95636434 |
| 20 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.94617981 |
| 21 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.93485081 |
| 22 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.92674664 |
| 23 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.92048982 |
| 24 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.91546359 |
| 25 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.87910719 |
| 26 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.80104230 |
| 27 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.78307739 |
| 28 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.74946118 |
| 29 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.69519242 |
| 30 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.60757419 |
| 31 | GATA1_22025678_ChIP-Seq_K562_Human | 1.58018707 |
| 32 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.56133281 |
| 33 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.54723016 |
| 34 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.53268160 |
| 35 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.48205781 |
| 36 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.46915043 |
| 37 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.46246519 |
| 38 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.45427978 |
| 39 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.43531747 |
| 40 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.40181063 |
| 41 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.38065470 |
| 42 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.37250236 |
| 43 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.37045710 |
| 44 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.37007375 |
| 45 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.36209516 |
| 46 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.36185767 |
| 47 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.35509318 |
| 48 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.32429785 |
| 49 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.31338185 |
| 50 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.25616601 |
| 51 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.25081025 |
| 52 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.24482471 |
| 53 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.24374158 |
| 54 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.24234414 |
| 55 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.22669553 |
| 56 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.21531448 |
| 57 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.21168989 |
| 58 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.19864066 |
| 59 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.19686307 |
| 60 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.19533505 |
| 61 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.19040168 |
| 62 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.18044329 |
| 63 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.14254169 |
| 64 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.13782908 |
| 65 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.12774062 |
| 66 | TP53_16413492_ChIP-PET_HCT116_Human | 1.12183267 |
| 67 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.11385380 |
| 68 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.10906814 |
| 69 | GATA1_19941826_ChIP-Seq_K562_Human | 1.10530647 |
| 70 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.10329120 |
| 71 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.08635418 |
| 72 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08519956 |
| 73 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.08009086 |
| 74 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.08009086 |
| 75 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.07976105 |
| 76 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.07976105 |
| 77 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.07359552 |
| 78 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.06168445 |
| 79 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.06168445 |
| 80 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.05722525 |
| 81 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.05284468 |
| 82 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.05091578 |
| 83 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.04893317 |
| 84 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.04345585 |
| 85 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.04318288 |
| 86 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.04228388 |
| 87 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.04040259 |
| 88 | GATA2_19941826_ChIP-Seq_K562_Human | 1.02838385 |
| 89 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.02468773 |
| 90 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.02078370 |
| 91 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.01703742 |
| 92 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.00933064 |
| 93 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.00489091 |
| 94 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99666833 |
| 95 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.99509854 |
| 96 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.98914156 |
| 97 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.98426620 |
| 98 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.97489076 |
| 99 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.96912782 |
| 100 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96682574 |
| 101 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.96137505 |
| 102 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.95681430 |
| 103 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.95266842 |
| 104 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.94765177 |
| 105 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94099673 |
| 106 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.91774024 |
| 107 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.91640760 |
| 108 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.91282959 |
| 109 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.91154129 |
| 110 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.91141006 |
| 111 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.90570428 |
| 112 | * SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.90304501 |
| 113 | MYB_26560356_Chip-Seq_TH1_Human | 0.90282420 |
| 114 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.89693416 |
| 115 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.89679447 |
| 116 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.89641709 |
| 117 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.89589919 |
| 118 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.89086019 |
| 119 | AR_25329375_ChIP-Seq_VCAP_Human | 0.88771389 |
| 120 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.88690780 |
| 121 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.88556356 |
| 122 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.88324432 |
| 123 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.88172449 |
| 124 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.87856698 |
| 125 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.87472588 |
| 126 | P300_19829295_ChIP-Seq_ESCs_Human | 0.87345358 |
| 127 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.87097669 |
| 128 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.86834600 |
| 129 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.86825528 |
| 130 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.86500210 |
| 131 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.86466210 |
| 132 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.85791737 |
| 133 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.85319737 |
| 134 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.85251678 |
| 135 | * CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.84702721 |
| 136 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.84557896 |
| 137 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.84338839 |
| 138 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.84214653 |
| 139 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.83067559 |
| 140 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.83060171 |
| 141 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.83054897 |
| 142 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.82265821 |
| 143 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.82086896 |
| 144 | CJUN_26792858_Chip-Seq_BT549_Human | 0.81807038 |
| 145 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.81638077 |
| 146 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.80416999 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005058_abnormal_lysosome_morphology | 4.68588412 |
| 2 | MP0003172_abnormal_lysosome_physiology | 4.53092680 |
| 3 | MP0005174_abnormal_tail_pigmentation | 3.81155412 |
| 4 | MP0000015_abnormal_ear_pigmentation | 3.15842372 |
| 5 | MP0005257_abnormal_intraocular_pressure | 2.67972374 |
| 6 | MP0000371_diluted_coat_color | 2.27049087 |
| 7 | MP0002419_abnormal_innate_immunity | 2.15995185 |
| 8 | MP0003075_altered_response_to | 2.15181779 |
| 9 | MP0009840_abnormal_foam_cell | 2.13575823 |
| 10 | MP0009278_abnormal_bone_marrow | 2.13475101 |
| 11 | MP0005451_abnormal_body_composition | 2.12435419 |
| 12 | MP0001835_abnormal_antigen_presentation | 2.12090399 |
| 13 | MP0003183_abnormal_peptide_metabolism | 2.06765691 |
| 14 | MP0003646_muscle_fatigue | 2.06055830 |
| 15 | MP0000343_altered_response_to | 2.05495537 |
| 16 | MP0006082_CNS_inflammation | 2.04999116 |
| 17 | MP0008004_abnormal_stomach_pH | 2.04068088 |
| 18 | MP0004510_myositis | 2.01888484 |
| 19 | MP0000569_abnormal_digit_pigmentation | 10.0925467 |
| 20 | MP0003303_peritoneal_inflammation | 1.97965567 |
| 21 | MP0003436_decreased_susceptibility_to | 1.97668851 |
| 22 | MP0005464_abnormal_platelet_physiology | 1.94583364 |
| 23 | MP0001958_emphysema | 1.92229352 |
| 24 | MP0003300_gastrointestinal_ulcer | 1.92166316 |
| 25 | MP0004381_abnormal_hair_follicle | 1.84285366 |
| 26 | MP0010307_abnormal_tumor_latency | 1.76873029 |
| 27 | MP0003690_abnormal_glial_cell | 1.68323015 |
| 28 | MP0005671_abnormal_response_to | 1.64867570 |
| 29 | MP0006054_spinal_hemorrhage | 1.62523753 |
| 30 | MP0003566_abnormal_cell_adhesion | 1.58603602 |
| 31 | MP0001501_abnormal_sleep_pattern | 1.53842927 |
| 32 | MP0005076_abnormal_cell_differentiation | 1.52404281 |
| 33 | MP0002139_abnormal_hepatobiliary_system | 1.49586004 |
| 34 | MP0005408_hypopigmentation | 1.49549593 |
| 35 | MP0000920_abnormal_myelination | 1.48773561 |
| 36 | MP0002166_altered_tumor_susceptibility | 1.47703110 |
| 37 | MP0005647_abnormal_sex_gland | 1.44931662 |
| 38 | MP0003191_abnormal_cellular_cholesterol | 1.41350548 |
| 39 | MP0002452_abnormal_antigen_presenting | 1.39614727 |
| 40 | MP0002837_dystrophic_cardiac_calcinosis | 1.39293763 |
| 41 | MP0005083_abnormal_biliary_tract | 1.38340187 |
| 42 | MP0005310_abnormal_salivary_gland | 1.36441495 |
| 43 | MP0005000_abnormal_immune_tolerance | 1.35636746 |
| 44 | MP0008260_abnormal_autophagy | 1.34364853 |
| 45 | MP0004947_skin_inflammation | 1.34051471 |
| 46 | MP0000604_amyloidosis | 1.34011422 |
| 47 | MP0003329_amyloid_beta_deposits | 1.30368310 |
| 48 | MP0005025_abnormal_response_to | 1.29873897 |
| 49 | MP0005166_decreased_susceptibility_to | 1.29787963 |
| 50 | MP0005360_urolithiasis | 1.28028321 |
| 51 | MP0003448_altered_tumor_morphology | 1.25559070 |
| 52 | MP0005075_abnormal_melanosome_morpholog | 1.23902011 |
| 53 | MP0001790_abnormal_immune_system | 1.23324298 |
| 54 | MP0005387_immune_system_phenotype | 1.23324298 |
| 55 | MP0001800_abnormal_humoral_immune | 1.21488855 |
| 56 | MP0002723_abnormal_immune_serum | 1.20935967 |
| 57 | MP0002090_abnormal_vision | 1.14099341 |
| 58 | MP0003633_abnormal_nervous_system | 1.12235087 |
| 59 | MP0005164_abnormal_response_to | 1.12047537 |
| 60 | MP0001324_abnormal_eye_pigmentation | 1.09497537 |
| 61 | MP0002998_abnormal_bone_remodeling | 1.09465218 |
| 62 | MP0003252_abnormal_bile_duct | 1.09208862 |
| 63 | MP0003195_calcinosis | 1.04832470 |
| 64 | MP0005197_abnormal_uvea_morphology | 1.03795636 |
| 65 | MP0003879_abnormal_hair_cell | 1.01010279 |
| 66 | MP0005165_increased_susceptibility_to | 1.00623369 |
| 67 | MP0001819_abnormal_immune_cell | 1.00309144 |
| 68 | MP0002006_tumorigenesis | 0.99419534 |
| 69 | MP0002075_abnormal_coat/hair_pigmentati | 0.99151526 |
| 70 | MP0003656_abnormal_erythrocyte_physiolo | 0.98750910 |
| 71 | MP0001533_abnormal_skeleton_physiology | 0.98589774 |
| 72 | MP0002420_abnormal_adaptive_immunity | 0.98114552 |
| 73 | MP0003705_abnormal_hypodermis_morpholog | 0.96702389 |
| 74 | MP0005167_abnormal_blood-brain_barrier | 0.95624182 |
| 75 | MP0008469_abnormal_protein_level | 0.93174734 |
| 76 | MP0003091_abnormal_cell_migration | 0.91531069 |
| 77 | MP0002928_abnormal_bile_duct | 0.91389068 |
| 78 | MP0005365_abnormal_bile_salt | 0.91339425 |
| 79 | MP0004043_abnormal_pH_regulation | 0.90409096 |
| 80 | MP0010155_abnormal_intestine_physiology | 0.89053321 |
| 81 | MP0000465_gastrointestinal_hemorrhage | 0.87866032 |
| 82 | MP0002095_abnormal_skin_pigmentation | 0.87374518 |
| 83 | MP0002138_abnormal_hepatobiliary_system | 0.87222699 |
| 84 | MP0005535_abnormal_body_temperature | 0.86478921 |
| 85 | MP0002254_reproductive_system_inflammat | 0.86379648 |
| 86 | MP0009046_muscle_twitch | 0.85633836 |
| 87 | MP0003453_abnormal_keratinocyte_physiol | 0.85411415 |
| 88 | MP0002405_respiratory_system_inflammati | 0.85073682 |
| 89 | MP0009763_increased_sensitivity_to | 0.81629399 |
| 90 | MP0005595_abnormal_vascular_smooth | 0.81483730 |
| 91 | MP0001845_abnormal_inflammatory_respons | 0.81469465 |
| 92 | MP0002148_abnormal_hypersensitivity_rea | 0.79364961 |
| 93 | MP0003631_nervous_system_phenotype | 0.78836995 |
| 94 | MP0005397_hematopoietic_system_phenotyp | 0.78602472 |
| 95 | MP0001545_abnormal_hematopoietic_system | 0.78602472 |
| 96 | MP0010352_gastrointestinal_tract_polyps | 0.78336892 |
| 97 | MP0001915_intracranial_hemorrhage | 0.77859424 |
| 98 | MP0001851_eye_inflammation | 0.77800962 |
| 99 | MP0000685_abnormal_immune_system | 0.77578257 |
| 100 | MP0003634_abnormal_glial_cell | 0.77399706 |
| 101 | MP0000609_abnormal_liver_physiology | 0.76594225 |
| 102 | MP0000858_altered_metastatic_potential | 0.76142664 |
| 103 | MP0000689_abnormal_spleen_morphology | 0.75945063 |
| 104 | MP0001186_pigmentation_phenotype | 0.75372430 |
| 105 | MP0002877_abnormal_melanocyte_morpholog | 0.74831307 |
| 106 | MP0002118_abnormal_lipid_homeostasis | 0.74191126 |
| 107 | MP0002332_abnormal_exercise_endurance | 0.73747470 |
| 108 | MP0010386_abnormal_urinary_bladder | 0.73488428 |
| 109 | MP0001542_abnormal_bone_strength | 0.73176573 |
| 110 | MP0009115_abnormal_fat_cell | 0.72702930 |
| 111 | MP0001243_abnormal_dermal_layer | 0.72054330 |
| 112 | MP0008438_abnormal_cutaneous_collagen | 0.71768330 |
| 113 | MP0002168_other_aberrant_phenotype | 0.71452024 |
| 114 | MP0005448_abnormal_energy_balance | 0.69959274 |
| 115 | MP0000767_abnormal_smooth_muscle | 0.69815956 |
| 116 | MP0003950_abnormal_plasma_membrane | 0.68035826 |
| 117 | MP0003632_abnormal_nervous_system | 0.67934209 |
| 118 | MP0005334_abnormal_fat_pad | 0.67796360 |
| 119 | MP0002693_abnormal_pancreas_physiology | 0.67077236 |
| 120 | MP0005410_abnormal_fertilization | 0.66072476 |
| 121 | MP0003724_increased_susceptibility_to | 0.65533481 |
| 122 | MP0003828_pulmonary_edema | 0.64926940 |
| 123 | MP0009764_decreased_sensitivity_to | 0.64832526 |
| 124 | MP0002396_abnormal_hematopoietic_system | 0.64671357 |
| 125 | MP0009785_altered_susceptibility_to | 0.64601764 |
| 126 | MP0001853_heart_inflammation | 0.62632712 |
| 127 | MP0005621_abnormal_cell_physiology | 0.62576083 |
| 128 | MP0000716_abnormal_immune_system | 0.61963173 |
| 129 | MP0008874_decreased_physiological_sensi | 0.61582365 |
| 130 | MP0002060_abnormal_skin_morphology | 0.61465621 |
| 131 | MP0002933_joint_inflammation | 0.61433293 |
| 132 | MP0008875_abnormal_xenobiotic_pharmacok | 0.61135068 |
| 133 | MP0004883_abnormal_blood_vessel | 0.60755556 |
| 134 | MP0003045_fibrosis | 0.60483378 |
| 135 | MP0010329_abnormal_lipoprotein_level | 0.60405224 |
| 136 | MP0000383_abnormal_hair_follicle | 0.59283759 |
| 137 | MP0005266_abnormal_metabolism | 0.58906100 |
| 138 | MP0000249_abnormal_blood_vessel | 0.58675712 |
| 139 | MP0001873_stomach_inflammation | 0.58415646 |
| 140 | MP0005171_absent_coat_pigmentation | 0.58129905 |
| 141 | MP0005666_abnormal_adipose_tissue | 0.58126662 |
| 142 | MP0001727_abnormal_embryo_implantation | 0.57712182 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 5.79523715 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 5.64789108 |
| 3 | Increased cerebral lipofuscin (HP:0011813) | 5.08218847 |
| 4 | Vacuolated lymphocytes (HP:0001922) | 4.61227725 |
| 5 | Neurofibrillary tangles (HP:0002185) | 4.27469830 |
| 6 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.24790366 |
| 7 | Mutism (HP:0002300) | 4.07231021 |
| 8 | Abnormality of glycolipid metabolism (HP:0010969) | 3.89502757 |
| 9 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.89502757 |
| 10 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.89502757 |
| 11 | Gingivitis (HP:0000230) | 3.85896957 |
| 12 | Axonal loss (HP:0003447) | 3.72596715 |
| 13 | Abnormality of macrophages (HP:0004311) | 3.71770305 |
| 14 | Prostate neoplasm (HP:0100787) | 3.62133515 |
| 15 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.61951464 |
| 16 | Periodontitis (HP:0000704) | 3.48985255 |
| 17 | Eczematoid dermatitis (HP:0000976) | 3.47580337 |
| 18 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.30190517 |
| 19 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.30190517 |
| 20 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.30190517 |
| 21 | Retrobulbar optic neuritis (HP:0100654) | 3.28620735 |
| 22 | Optic neuritis (HP:0100653) | 3.28620735 |
| 23 | Dysostosis multiplex (HP:0000943) | 3.28469329 |
| 24 | Disinhibition (HP:0000734) | 3.28402149 |
| 25 | Nuclear cataract (HP:0100018) | 3.27012264 |
| 26 | Asymmetric septal hypertrophy (HP:0001670) | 3.24577159 |
| 27 | Thick nail (HP:0001805) | 3.14667539 |
| 28 | Pathologic fracture (HP:0002756) | 3.14345163 |
| 29 | Recurrent skin infections (HP:0001581) | 3.14329732 |
| 30 | Cerebral inclusion bodies (HP:0100314) | 3.14010057 |
| 31 | Apathy (HP:0000741) | 3.13605323 |
| 32 | Stomatitis (HP:0010280) | 3.04549370 |
| 33 | Premature loss of primary teeth (HP:0006323) | 3.04325961 |
| 34 | Myocardial infarction (HP:0001658) | 3.01847057 |
| 35 | Complement deficiency (HP:0004431) | 3.00984924 |
| 36 | Orchitis (HP:0100796) | 2.99570997 |
| 37 | Global brain atrophy (HP:0002283) | 2.99493925 |
| 38 | Diminished motivation (HP:0000745) | 2.97659216 |
| 39 | Metaphyseal irregularity (HP:0003025) | 2.97164402 |
| 40 | Mucopolysacchariduria (HP:0008155) | 2.94795368 |
| 41 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.94795368 |
| 42 | Submucous cleft hard palate (HP:0000176) | 2.94736261 |
| 43 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.83012015 |
| 44 | Joint hemorrhage (HP:0005261) | 2.81048889 |
| 45 | Autoimmune thrombocytopenia (HP:0001973) | 2.81030497 |
| 46 | Peripheral demyelination (HP:0011096) | 2.79434360 |
| 47 | Gingival bleeding (HP:0000225) | 2.79050512 |
| 48 | Distal lower limb amyotrophy (HP:0008944) | 2.66981140 |
| 49 | Upper motor neuron abnormality (HP:0002127) | 2.63591606 |
| 50 | Bone pain (HP:0002653) | 2.59505488 |
| 51 | Loss of speech (HP:0002371) | 2.59308706 |
| 52 | Absent frontal sinuses (HP:0002688) | 2.56406468 |
| 53 | Tetany (HP:0001281) | 2.51954713 |
| 54 | Generalized hypopigmentation (HP:0007513) | 2.48770864 |
| 55 | Abnormality of the periventricular white matter (HP:0002518) | 2.45010769 |
| 56 | Aplasia/Hypoplasia of the macula (HP:0008059) | 2.44964829 |
| 57 | Hypophosphatemia (HP:0002148) | 2.44311383 |
| 58 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.42940209 |
| 59 | Hypercholesterolemia (HP:0003124) | 2.40290707 |
| 60 | Basal ganglia calcification (HP:0002135) | 2.39029395 |
| 61 | Amyloidosis (HP:0011034) | 2.36387816 |
| 62 | Urethral obstruction (HP:0000796) | 2.36381883 |
| 63 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.31484148 |
| 64 | Ocular albinism (HP:0001107) | 2.30992920 |
| 65 | Abnormality of vision evoked potentials (HP:0000649) | 2.30850116 |
| 66 | Increased CSF protein (HP:0002922) | 2.29947598 |
| 67 | Interstitial pulmonary disease (HP:0006530) | 2.28912983 |
| 68 | Abnormality of the fingertips (HP:0001211) | 2.27819608 |
| 69 | Dementia (HP:0000726) | 2.27605852 |
| 70 | Nausea (HP:0002018) | 2.27062277 |
| 71 | Myositis (HP:0100614) | 2.26704651 |
| 72 | Progressive neurologic deterioration (HP:0002344) | 2.25079374 |
| 73 | Neurodegeneration (HP:0002180) | 2.24467706 |
| 74 | Large earlobe (HP:0009748) | 2.23875836 |
| 75 | Hematochezia (HP:0002573) | 2.23187752 |
| 76 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.22789312 |
| 77 | Neuronal loss in central nervous system (HP:0002529) | 2.22585652 |
| 78 | Chromsome breakage (HP:0040012) | 2.22138139 |
| 79 | Keratoconjunctivitis sicca (HP:0001097) | 2.21430630 |
| 80 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 2.17336071 |
| 81 | Intrahepatic cholestasis (HP:0001406) | 2.17331484 |
| 82 | Thoracic kyphosis (HP:0002942) | 2.17310229 |
| 83 | Upper limb muscle weakness (HP:0003484) | 2.16152278 |
| 84 | Mediastinal lymphadenopathy (HP:0100721) | 2.14963478 |
| 85 | Retinal atrophy (HP:0001105) | 2.12947044 |
| 86 | Slow saccadic eye movements (HP:0000514) | 2.12227171 |
| 87 | Protuberant abdomen (HP:0001538) | 2.09786822 |
| 88 | Osteomyelitis (HP:0002754) | 2.09442070 |
| 89 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.09330044 |
| 90 | Abnormality of complement system (HP:0005339) | 2.08999358 |
| 91 | Recurrent fungal infections (HP:0002841) | 2.08530796 |
| 92 | Turricephaly (HP:0000262) | 2.08127845 |
| 93 | Skin nodule (HP:0200036) | 2.07353333 |
| 94 | Purpura (HP:0000979) | 2.04965889 |
| 95 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.04597781 |
| 96 | Keratoconjunctivitis (HP:0001096) | 2.03076671 |
| 97 | Bruising susceptibility (HP:0000978) | 2.01638909 |
| 98 | Abnormality of the thoracic spine (HP:0100711) | 2.00967233 |
| 99 | Conjunctival telangiectasia (HP:0000524) | 1.99370985 |
| 100 | Lower limb amyotrophy (HP:0007210) | 1.99255283 |
| 101 | Systemic lupus erythematosus (HP:0002725) | 1.98893593 |
| 102 | Xanthomatosis (HP:0000991) | 1.98005800 |
| 103 | Frequent falls (HP:0002359) | 1.97599126 |
| 104 | Pulmonary infiltrates (HP:0002113) | 1.95081064 |
| 105 | Distal lower limb muscle weakness (HP:0009053) | 1.92564990 |
| 106 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.92362948 |
| 107 | Polyneuropathy (HP:0001271) | 1.90669819 |
| 108 | Elevated alkaline phosphatase (HP:0003155) | 1.89192842 |
| 109 | Reticulocytosis (HP:0001923) | 1.88709153 |
| 110 | Supranuclear gaze palsy (HP:0000605) | 1.88367358 |
| 111 | Steatorrhea (HP:0002570) | 1.88229348 |
| 112 | Epidermoid cyst (HP:0200040) | 1.87934261 |
| 113 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.86935801 |
| 114 | Osteolytic defects of the hand bones (HP:0009699) | 1.86935801 |
| 115 | Pulmonary artery stenosis (HP:0004415) | 1.86139387 |
| 116 | Prolonged neonatal jaundice (HP:0006579) | 1.85441890 |
| 117 | Inappropriate behavior (HP:0000719) | 1.85276221 |
| 118 | Gangrene (HP:0100758) | 1.84798205 |
| 119 | Abnormality of the lumbar spine (HP:0100712) | 1.84157719 |
| 120 | Albinism (HP:0001022) | 1.83611718 |
| 121 | Abnormality of the frontal sinuses (HP:0002687) | 1.82945590 |
| 122 | Chronic obstructive pulmonary disease (HP:0006510) | 1.82304689 |
| 123 | Obstructive lung disease (HP:0006536) | 1.82304689 |
| 124 | Sensorimotor neuropathy (HP:0007141) | 1.81621087 |
| 125 | Abnormality of primary teeth (HP:0006481) | 1.81007819 |
| 126 | Cardiomegaly (HP:0001640) | 1.80455727 |
| 127 | Agnosia (HP:0010524) | 1.79208141 |
| 128 | Ovoid vertebral bodies (HP:0003300) | 1.78824910 |
| 129 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.78382999 |
| 130 | Long toe (HP:0010511) | 1.77799265 |
| 131 | Zonular cataract (HP:0010920) | 1.77461555 |
| 132 | Impaired platelet aggregation (HP:0003540) | 1.76672284 |
| 133 | Abnormal platelet function (HP:0011869) | 1.76672284 |
| 134 | Abnormality of the basal ganglia (HP:0002134) | 1.76175844 |
| 135 | Glomerulonephritis (HP:0000099) | 1.76010538 |
| 136 | Epistaxis (HP:0000421) | 1.75034091 |
| 137 | Hyperventilation (HP:0002883) | 1.74333998 |
| 138 | Esophageal varix (HP:0002040) | 1.74040583 |
| 139 | Hepatosplenomegaly (HP:0001433) | 1.73938945 |
| 140 | Iris hypopigmentation (HP:0007730) | 1.73877329 |
| 141 | Increased serum ferritin (HP:0003281) | 1.73090194 |
| 142 | Tetraparesis (HP:0002273) | 1.73063776 |
| 143 | Menorrhagia (HP:0000132) | 1.73009081 |
| 144 | Memory impairment (HP:0002354) | 1.72634762 |
| 145 | Parakeratosis (HP:0001036) | 1.72346572 |
| 146 | Progressive hearing impairment (HP:0001730) | 1.71670410 |
| 147 | Ectopic kidney (HP:0000086) | 1.71664151 |
| 148 | Acne (HP:0001061) | 1.69624682 |
| 149 | Hemoptysis (HP:0002105) | 1.69154551 |
| 150 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.68197716 |
| 151 | Malnutrition (HP:0004395) | 1.66925770 |
| 152 | Vertigo (HP:0002321) | 1.66895949 |
| 153 | Nephritis (HP:0000123) | 1.66694885 |
| 154 | Joint swelling (HP:0001386) | 1.65799929 |
| 155 | Bundle branch block (HP:0011710) | 1.64987276 |
| 156 | Action tremor (HP:0002345) | 1.62674403 |
| 157 | Postural tremor (HP:0002174) | 1.61825649 |
| 158 | Fat malabsorption (HP:0002630) | 1.57441165 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAOK3 | 4.15587472 |
| 2 | GRK7 | 3.66849877 |
| 3 | IRAK3 | 3.53037882 |
| 4 | DDR2 | 3.45672315 |
| 5 | KIT | 3.25545071 |
| 6 | MAP3K14 | 3.23710529 |
| 7 | CDK12 | 3.21659111 |
| 8 | CAMK1D | 3.16803401 |
| 9 | ACVR1B | 2.91736376 |
| 10 | CAMK1G | 2.86056472 |
| 11 | RIPK4 | 2.45479982 |
| 12 | IRAK4 | 2.42331285 |
| 13 | MATK | 2.36612695 |
| 14 | TTN | 2.22460606 |
| 15 | TAOK1 | 2.11971167 |
| 16 | SIK2 | 2.09579323 |
| 17 | BRD4 | 2.07673473 |
| 18 | TAOK2 | 2.01859089 |
| 19 | TYK2 | 1.90058208 |
| 20 | ADRBK2 | 1.88275385 |
| 21 | TBK1 | 1.84436910 |
| 22 | MAP3K13 | 1.75668071 |
| 23 | PTK6 | 1.73545325 |
| 24 | BMPR2 | 1.68430406 |
| 25 | IKBKB | 1.63105761 |
| 26 | MOS | 1.63064824 |
| 27 | CDK6 | 1.53895828 |
| 28 | IKBKE | 1.52302554 |
| 29 | CDC42BPA | 1.50475684 |
| 30 | JAK1 | 1.47733000 |
| 31 | FES | 1.44027243 |
| 32 | FRK | 1.40691263 |
| 33 | INSRR | 1.38512012 |
| 34 | HCK | 1.38225419 |
| 35 | CSF1R | 1.37941910 |
| 36 | BLK | 1.36919853 |
| 37 | PKN1 | 1.33379685 |
| 38 | EPHB1 | 1.31652882 |
| 39 | CHUK | 1.31218852 |
| 40 | FGR | 1.30055963 |
| 41 | LATS2 | 1.20579651 |
| 42 | TRPM7 | 1.19153518 |
| 43 | IRAK1 | 1.17670988 |
| 44 | TGFBR2 | 1.17018604 |
| 45 | JAK3 | 1.14237064 |
| 46 | STK24 | 1.11545095 |
| 47 | AKT3 | 1.10106481 |
| 48 | DAPK2 | 1.09891449 |
| 49 | EPHA3 | 1.09870085 |
| 50 | MAP3K11 | 1.09790823 |
| 51 | TYRO3 | 1.09693145 |
| 52 | CSK | 1.09516543 |
| 53 | ICK | 1.09383810 |
| 54 | NME2 | 1.07670715 |
| 55 | PIM2 | 1.06763882 |
| 56 | SGK2 | 1.05582973 |
| 57 | SGK3 | 1.05016130 |
| 58 | NEK9 | 1.02564934 |
| 59 | IRAK2 | 1.02463091 |
| 60 | MAP3K5 | 1.01928788 |
| 61 | STK4 | 0.99971429 |
| 62 | MTOR | 0.97474318 |
| 63 | MAP3K1 | 0.96956258 |
| 64 | FGFR3 | 0.89581926 |
| 65 | RIPK1 | 0.87695190 |
| 66 | STK3 | 0.87683522 |
| 67 | EGFR | 0.86702986 |
| 68 | MAPK7 | 0.85293349 |
| 69 | JAK2 | 0.84116119 |
| 70 | PBK | 0.83928754 |
| 71 | LCK | 0.83762033 |
| 72 | SGK1 | 0.83653813 |
| 73 | PDGFRB | 0.83085931 |
| 74 | NTRK3 | 0.82086900 |
| 75 | YES1 | 0.81476651 |
| 76 | MARK3 | 0.79487845 |
| 77 | PTK2 | 0.79138695 |
| 78 | OBSCN | 0.78834207 |
| 79 | ABL1 | 0.78197207 |
| 80 | MAP3K9 | 0.77117825 |
| 81 | WNK1 | 0.74546030 |
| 82 | MAP3K3 | 0.74011723 |
| 83 | MAP2K6 | 0.72997049 |
| 84 | PDGFRA | 0.71582058 |
| 85 | MAP3K2 | 0.70502804 |
| 86 | CLK1 | 0.70039557 |
| 87 | LYN | 0.68255584 |
| 88 | SYK | 0.66003665 |
| 89 | PIM1 | 0.65380584 |
| 90 | EIF2AK2 | 0.65277325 |
| 91 | MAPK12 | 0.65124683 |
| 92 | ZAP70 | 0.65072109 |
| 93 | ERN1 | 0.65057112 |
| 94 | SCYL2 | 0.63852652 |
| 95 | MAPK4 | 0.62976294 |
| 96 | MAP3K10 | 0.62164640 |
| 97 | MARK1 | 0.62119686 |
| 98 | CAMKK2 | 0.61239029 |
| 99 | MAPK10 | 0.60826773 |
| 100 | DYRK3 | 0.59900610 |
| 101 | ERBB2 | 0.59751599 |
| 102 | GSK3A | 0.59700593 |
| 103 | PDK2 | 0.58730252 |
| 104 | TXK | 0.57326680 |
| 105 | MAP4K1 | 0.57183175 |
| 106 | PRPF4B | 0.55975308 |
| 107 | SGK223 | 0.55750608 |
| 108 | SGK494 | 0.55750608 |
| 109 | MAP2K3 | 0.54667516 |
| 110 | PRKAA2 | 0.53942637 |
| 111 | HIPK2 | 0.53243941 |
| 112 | ZAK | 0.52897369 |
| 113 | PDK1 | 0.51568019 |
| 114 | TNIK | 0.49816610 |
| 115 | FYN | 0.49584835 |
| 116 | KSR1 | 0.46516426 |
| 117 | FER | 0.46146149 |
| 118 | RPS6KA2 | 0.45397278 |
| 119 | PDPK1 | 0.45327408 |
| 120 | MELK | 0.43271997 |
| 121 | MET | 0.42227376 |
| 122 | SIK1 | 0.42044734 |
| 123 | KSR2 | 0.41927494 |
| 124 | LATS1 | 0.41764664 |
| 125 | CDK9 | 0.40594972 |
| 126 | NLK | 0.40578826 |
| 127 | CAMK4 | 0.39993415 |
| 128 | CASK | 0.39186406 |
| 129 | ITK | 0.39025195 |
| 130 | ERBB4 | 0.38254524 |
| 131 | AKT1 | 0.38164816 |
| 132 | CSNK1A1L | 0.37758517 |
| 133 | BMX | 0.36702064 |
| 134 | INSR | 0.36270883 |
| 135 | NUAK1 | 0.34925208 |
| 136 | SRC | 0.33843355 |
| 137 | ATR | 0.33558832 |
| 138 | MARK2 | 0.33013719 |
| 139 | ATM | 0.32475551 |
| 140 | FLT3 | 0.31772118 |
| 141 | RPS6KL1 | 0.31616897 |
| 142 | RPS6KC1 | 0.31616897 |
| 143 | MAPK1 | 0.31475874 |
| 144 | ABL2 | 0.31052890 |
| 145 | PRKACG | 0.30976635 |
| 146 | PAK4 | 0.30914285 |
| 147 | PRKG1 | 0.30619712 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Caffeine metabolism_Homo sapiens_hsa00232 | 3.34167195 |
| 2 | Lysosome_Homo sapiens_hsa04142 | 3.04809137 |
| 3 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.04357094 |
| 4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.67586309 |
| 5 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.65869312 |
| 6 | Other glycan degradation_Homo sapiens_hsa00511 | 2.19854860 |
| 7 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.10754560 |
| 8 | Lysine degradation_Homo sapiens_hsa00310 | 1.96572440 |
| 9 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.88253291 |
| 10 | Leishmaniasis_Homo sapiens_hsa05140 | 1.84518566 |
| 11 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.83383715 |
| 12 | Tuberculosis_Homo sapiens_hsa05152 | 1.76876573 |
| 13 | Malaria_Homo sapiens_hsa05144 | 1.75971342 |
| 14 | Phagosome_Homo sapiens_hsa04145 | 1.73925365 |
| 15 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.72554145 |
| 16 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.70752047 |
| 17 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.58268798 |
| 18 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.55472142 |
| 19 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.52240924 |
| 20 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.50015013 |
| 21 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.45239505 |
| 22 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.40896535 |
| 23 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.40018308 |
| 24 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.34035187 |
| 25 | ABC transporters_Homo sapiens_hsa02010 | 1.30100743 |
| 26 | Pertussis_Homo sapiens_hsa05133 | 1.24688654 |
| 27 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.24140661 |
| 28 | Measles_Homo sapiens_hsa05162 | 1.22447906 |
| 29 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.20990160 |
| 30 | Apoptosis_Homo sapiens_hsa04210 | 1.19370829 |
| 31 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.18468511 |
| 32 | Influenza A_Homo sapiens_hsa05164 | 1.18360364 |
| 33 | Prion diseases_Homo sapiens_hsa05020 | 1.17675726 |
| 34 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.17536505 |
| 35 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.16988717 |
| 36 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.14528281 |
| 37 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.11840216 |
| 38 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.04743498 |
| 39 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.03136897 |
| 40 | Hepatitis C_Homo sapiens_hsa05160 | 0.98550694 |
| 41 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.97456996 |
| 42 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.97298850 |
| 43 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.97045143 |
| 44 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.93730174 |
| 45 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.92982342 |
| 46 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.90466642 |
| 47 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.90336888 |
| 48 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.89300617 |
| 49 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.87495502 |
| 50 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.85547951 |
| 51 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.83098688 |
| 52 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.82403180 |
| 53 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.81337945 |
| 54 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.81232983 |
| 55 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.80768192 |
| 56 | Insulin resistance_Homo sapiens_hsa04931 | 0.80544788 |
| 57 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.80390629 |
| 58 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.77602046 |
| 59 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.76338378 |
| 60 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.76017686 |
| 61 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.74699194 |
| 62 | Legionellosis_Homo sapiens_hsa05134 | 0.74636516 |
| 63 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.73588788 |
| 64 | Circadian rhythm_Homo sapiens_hsa04710 | 0.73231865 |
| 65 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.69425655 |
| 66 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.68442577 |
| 67 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.68398959 |
| 68 | Amoebiasis_Homo sapiens_hsa05146 | 0.67642263 |
| 69 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.67436843 |
| 70 | Salmonella infection_Homo sapiens_hsa05132 | 0.66335379 |
| 71 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.65986677 |
| 72 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.65807509 |
| 73 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.65202428 |
| 74 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.64835785 |
| 75 | Renin secretion_Homo sapiens_hsa04924 | 0.64741142 |
| 76 | Hepatitis B_Homo sapiens_hsa05161 | 0.64197102 |
| 77 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.60637371 |
| 78 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.60243014 |
| 79 | Prostate cancer_Homo sapiens_hsa05215 | 0.59878893 |
| 80 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.59392133 |
| 81 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.58484270 |
| 82 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.58304800 |
| 83 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.58078007 |
| 84 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.57920733 |
| 85 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.57273227 |
| 86 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.56772171 |
| 87 | Bladder cancer_Homo sapiens_hsa05219 | 0.56761417 |
| 88 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.55533817 |
| 89 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.55039987 |
| 90 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.54835081 |
| 91 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.54769293 |
| 92 | Viral myocarditis_Homo sapiens_hsa05416 | 0.53066605 |
| 93 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.50497001 |
| 94 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.49760764 |
| 95 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.49633729 |
| 96 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.49207472 |
| 97 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.49159829 |
| 98 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.49016889 |
| 99 | Endocytosis_Homo sapiens_hsa04144 | 0.47734825 |
| 100 | Histidine metabolism_Homo sapiens_hsa00340 | 0.47495194 |
| 101 | Platelet activation_Homo sapiens_hsa04611 | 0.47376201 |
| 102 | Asthma_Homo sapiens_hsa05310 | 0.46973754 |
| 103 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.46295946 |
| 104 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.45968237 |
| 105 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.45948325 |
| 106 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.45785956 |
| 107 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.45746510 |
| 108 | Retinol metabolism_Homo sapiens_hsa00830 | 0.45402459 |
| 109 | Bile secretion_Homo sapiens_hsa04976 | 0.44366988 |
| 110 | Shigellosis_Homo sapiens_hsa05131 | 0.44095017 |
| 111 | Melanoma_Homo sapiens_hsa05218 | 0.43847375 |
| 112 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.42520670 |
| 113 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.42429126 |
| 114 | Allograft rejection_Homo sapiens_hsa05330 | 0.42227692 |
| 115 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.41650067 |
| 116 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.41492455 |
| 117 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.41469265 |
| 118 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.41395878 |
| 119 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.41384717 |
| 120 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.41107082 |
| 121 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.40425092 |
| 122 | Mineral absorption_Homo sapiens_hsa04978 | 0.40165156 |
| 123 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.36013392 |
| 124 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.34712767 |
| 125 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.32195659 |
| 126 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.31868675 |
| 127 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.30882268 |
| 128 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.28473881 |
| 129 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.28055177 |
| 130 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.27930891 |
| 131 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.27642785 |
| 132 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.26020467 |
| 133 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.25178998 |
| 134 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.23898409 |
| 135 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.22920889 |
| 136 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.22368388 |

